Summit Therapeutics Inc Forecast and Target Price

$18.24

Summit Therapeutics Inc (SMMT) Share Price Forecast

Currently 7 wall-street analysts regularly analyze the financials of Summit Therapeutics Inc on a frequent basis to provide recommendations along with target share price. 7 analysts offering 12-month price forecasts for Summit Therapeutics Inc (SMMT) have a share price target of $32.52. This median of share price forecast represents a 78.31% upside from the latest price of $18.24 as on 07.01.25.

Summit Therapeutics Inc (SMMT) Price vs Consensus Price Target

Price

Target Price

As per the chart shown above, analysts believe that the Summit Therapeutics Inc (SMMT) share price will touch around $32.52 in next 12-months.

Summit Therapeutics Inc (SMMT) Share Price Forecast v/s Share Price Today

Below is a chart showing the percentage difference between Summit Therapeutics Inc's share price and its median forecast price. As on 07.01.25, the difference is -29.75%

Summit Therapeutics Inc (SMMT): Difference between Current Price & Median Forecasted Price

Difference in Percentage terms

Summit Therapeutics Inc (SMMT) Share Price Technical Analysis

50 Day Moving Average v/s Current Share Price

Moving Average

Price

200 Day Moving Average v/s Current Share Price

Moving Average

Price

Become a Global Investor

Start Investing in brands you love

₹0 US Stocks a/c Opening Fee
₹0 Maintenance Charges
₹0 US Stocks Withdrawals*

Invest Now

*Investment in securities market are subject to market risk, read all the related documents carefully before investing. Logos above are the property of their respective trademark owners and by displaying it INDmoney has no right, title or interest over it.

The connector service for US Stocks account is provided by Finzoomers Services Private Limited.

Please be informed that US Stocks are not Indian Exchange traded funds and Finzoomers Services Private Limited merely acts in the capacity of a facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to exchange investor redressal forum or arbitration mechanism in India. The securities quoted are for examples and not to be considered as an advice or recommendation.